Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Tibial Nerve Block for Pain After Hallux Valgus Surgery
NCT02282956Phase 4Unknown
- Start
- Oct 2014
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Morphine requirement at 24 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02282956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282956.